**HEALTH INTELLIGENCE: The Silent Cost of Antibiotic Resistance** The WHO estimates antimicrobial resistance causes 1.27 million deaths annually and could trigger 10 million deaths per year by 2050 if unchecked—surpassing cancer mortality. Historically, antibiotics transformed medicine after penicillin's 1928 discovery, reducing bacterial infection deaths from 30% to under 5% by the 1960s, but overuse in agriculture (70% of US antibiotic tonnage goes to livestock) and improper dosing have accelerated resistance development at an unprecedented pace. This matters because common infections—UTIs, pneumonia, surgical complications—are becoming untreatable with existing drugs, forcing medicine backward toward pre-antibiotic era risks while new drug development has stalled (only 12 new antibiotics approved 2010-2023 versus 40+ in the 1980s). The economic impact: an estimated $1 trillion in healthcare costs by 2050, making this a converging crisis of epidemiology, agriculture policy, and pharmaceutical economics that directly affects treatment outcomes for billions globally.